联环药业: 联环药业关于公司独立董事变动的公告

Group 1 - The independent director Chen Ying has resigned from her position at Jiangsu Lianhuan Pharmaceutical Co., Ltd. due to the completion of her six-year term, in compliance with regulations [1][2] - Chen Ying's resignation will not reduce the number of independent directors below one-third of the board, but it will affect the composition of the board's specialized committees [1] - The resignation will take effect after the company elects a new independent director, during which Chen Ying will continue to fulfill her duties [1] Group 2 - The company has nominated Wu Fang as the candidate for the new independent director, pending approval from the Shanghai Stock Exchange and the shareholders' meeting [2] - Wu Fang has not yet obtained the qualification training certificate required by the Shanghai Stock Exchange but has committed to complete the necessary training [2] - Wu Fang's term will last until the end of the ninth board's term, starting from the date of approval by the shareholders' meeting [2] Group 3 - Wu Fang meets the qualifications to serve as an independent director and has not been subject to any disqualifying conditions as per the Company Law [3] - She has not faced any administrative penalties from the China Securities Regulatory Commission in the last three years and has not been publicly reprimanded by the stock exchange [3] - Wu Fang does not hold any shares in the company [3]